Bacteroides fragilis Lipopolysaccharide and Inflammatory Signaling in Alzheimer's Disease

• Published in: Frontiers in microbiology Vol. 7; p. 1544
• Main Author: Lukiw, Walter J
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 26.09.2016
• Subjects: Alzheimer’s disease (AD); DAMPs; lipopolysaccharides (LPS); Microbiology; NF-kB; PAMPS; systemic inflammation; systemic inflammation; lipopolysaccharides; Alzheimer’s disease; DAMPs and PAMPs; NF-kB; 42 amino acid amyloid-beta (Aβ42) peptides; bacteroidetes; microbiome
• ISSN: 1664-302X; 1664-302X
• DOI: 10.3389/fmicb.2016.01544

The human microbiome consists of ~3.8 × 10 symbiotic microorganisms that form a highly complex and dynamic ecosystem: the gastrointestinal (GI) tract constitutes the largest repository of the human microbiome by far, and its impact on human neurological health and disease is becoming increasingly appreciated. Bacteroidetes, the largest phylum of Gram-negative bacteria in the GI tract microbiome, while generally beneficial to the host when confined to the GI tract, have potential to secrete a remarkably complex array of pro-inflammatory neurotoxins that include surface lipopolysaccharides (LPSs) and toxic proteolytic peptides. The deleterious effects of these bacterial exudates appear to become more important as GI tract and blood-brain barriers alter or increase their permeability with aging and disease. For example, presence of the unique LPSs of the abundant Bacteroidetes species in the serum represents a major contributing factor to systemic inflammation. BF-LPS is further recognized by TLR2, TLR4, and/or CD14 microglial cell receptors as are the pro-inflammatory 42 amino acid amyloid-beta (Aβ42) peptides that characterize Alzheimer's disease (AD) brain. Here we provide the first evidence that BF-LPS exposure to human primary brain cells is an exceptionally potent inducer of the pro-inflammatory transcription factor NF-kB (p50/p65) complex, a known trigger in the expression of pathogenic pathways involved in inflammatory neurodegeneration. This will in addition highlight work from recent studies that advance novel and emerging concepts on the potential contribution of microbiome-generated factors, such as BF-LPS, in driving pro-inflammatory degenerative neuropathology in the AD brain.